Organigram Global (OGI) EBITDA (2018 - 2026)

Organigram Global (OGI) has 7 years of EBITDA data on file, last reported at -$13.9 million in Q1 2026.

• On a quarterly basis, EBITDA fell 162.32% year-over-year to -$13.9 million in Q1 2026; TTM through Mar 2026 was -$18.6 million, a 16.68% increase from a year earlier, with the FY2025 full-year figure at -$8.5 million, changed N/A from the prior year.
• EBITDA for Q1 2026 stood at -$13.9 million, down from $5.4 million in the prior quarter.
• Over the last five years, EBITDA for OGI reached as high as $5.4 million in Q4 2025 and fell as low as -$13.9 million in Q1 2026.
• Historically, EBITDA has averaged -$4.7 million across 3 years, with a median of -$5.1 million in 2024.
• Across the five-year window, EBITDA surged 210.47% in 2025 and tumbled 162.32% in 2026, its largest moves.
• Year by year, EBITDA stood at -$4.9 million in 2024, then jumped by 210.47% to $5.4 million in 2025, then plunged by 357.76% to -$13.9 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$13.9 million in Q1 2026, $5.4 million in Q4 2025, and -$5.3 million in Q1 2025.